Status:
COMPLETED
Diabetes Homeless Medication Support
Lead Sponsor:
Hennepin Healthcare Research Institute
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Diabetes Mellitus, Type 2
Housing Problems
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This randomized pilot trial of the Diabetes Homeless Medication Support intervention vs. brief diabetes education will test the perception and feasibility of anticipated study procedures and refine ra...
Detailed Description
This study has an overall goal to develop and pilot test a collaborative care intervention using motivational interviewing and behavioral activation alongside education and psychosocial support to imp...
Eligibility Criteria
Inclusion
- Age 18 yrs. or older
- English-speaking
- Homelessness by federal definition (HEARTH ACT) in the past 24 mos.
- Self-reported diagnosis of type 2 diabetes with A1c \>7.5%, later verified in medical record and study point-of-care lab test.
- Plan to stay in local area or be reachable by phone for the next 24 weeks
- Willingness to work on medication adherence and diabetes self-care
Exclusion
- Inability to provide informed consent (e.g., presence of a legal guardian, prisoners)
- Active psychosis or intoxication precluding ability to give informed consent
- Pregnant or lactating people
Key Trial Info
Start Date :
February 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 12 2023
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05258630
Start Date
February 23 2022
End Date
July 12 2023
Last Update
November 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hennepin Healthcare
Minneapolis, Minnesota, United States, 55415